4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol triphenylacetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 8 USDMF, 3 EU WC, 1 KDMF, 10 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

109 Drugs in Development

109 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

42 FDF Dossiers, 6 FDA Orange Book, 30 Europe, 5 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH

RELATED EXCIPIENT COMPANIES

2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 DFE Pharma, 9 Kerry, 7 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Pluviaendo, 1 Prachin Chemical, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Silverline Chemicals, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

14 Fillers, Diluents & Binders, 8 Lubricants & Glidants, 7 Granulation, 5 Direct Compression, 2 Co-Processed Excipients, 1 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Parenteral